Guideline
doi: 10.1590/1806-9282.63.02.95.
Treatment of benign prostatic hyperplasia
Affiliations
- PMID: 28355368
- DOI: 10.1590/1806-9282.63.02.95
Item in Clipboard
Guideline
Treatment of benign prostatic hyperplasia
Rev Assoc Med Bras (1992).
2017 Feb.
Free article
No abstract available
Similar articles
-
Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms.N Engl J Med. 2012 Jul 19;367(3):248-57. doi: 10.1056/NEJMcp1106637. N Engl J Med. 2012. PMID: 22808960 Review. No abstract available.
-
α-Blockers, 5-α-Reductase Inhibitors, Acetylcholine, β3 Agonists, and Phosphodiesterase-5s in Medical Management of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: How Much Do the Different Formulations Actually Matter in the Classes?Urol Clin North Am. 2016 Aug;43(3):351-6. doi: 10.1016/j.ucl.2016.04.013. Urol Clin North Am. 2016. PMID: 27476127 Review.
-
Combination therapy for non-neurogenic male lower urinary tract symptoms: 1 + 1 does not equal 2.Eur Urol. 2013 Aug;64(2):244-6; discussion 246-7. doi: 10.1016/j.eururo.2013.02.021. Epub 2013 Feb 19. Eur Urol. 2013. PMID: 23473577 No abstract available.
-
Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015.Curr Opin Urol. 2015 Jan;25(1):6-11. doi: 10.1097/MOU.0000000000000120. Curr Opin Urol. 2015. PMID: 25393269 Review.
-
Antimuscarinics, β-3 Agonists, and Phosphodiesterase Inhibitors in the Treatment of Male Lower Urinary Tract Symptoms: An Evolving Paradigm.Urol Clin North Am. 2016 Aug;43(3):337-49. doi: 10.1016/j.ucl.2016.04.004. Urol Clin North Am. 2016. PMID: 27476126 Review.
Cited by
-
Potential Therapeutic Effects of Underground Parts of Kalanchoe gastonis-bonnieri on Benign Prostatic Hyperplasia.Evid Based Complement Alternat Med. 2019 Jan 2;2019:6340757. doi: 10.1155/2019/6340757. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 30719063 Free PMC article.
-
Comparative efficacy of 450 nm blue-laser vaporization versus transurethral plasma kinetic enucleation of the prostate (TUPKEP) for benign prostatic hyperplasia in high-risk elderly patients: a focus on safety, efficacy, and sexual function preservation.Lasers Med Sci. 2025 Jun 23;40(1):294. doi: 10.1007/s10103-025-04547-z. Lasers Med Sci. 2025. PMID: 40549059
-
[Comparison of efficacy and safety of transurethral thulium fiber laser enucleation of prostate in patients with different prostate volumes].Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Aug 18;57(4):711-716. doi: 10.19723/j.issn.1671-167X.2025.04.013. Beijing Da Xue Xue Bao Yi Xue Ban. 2025. PMID: 40754908 Free PMC article. Chinese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
